Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drew Scientific doubles interim turnover:

This article was originally published in Clinica

Executive Summary

Drew Scientific, UK-based manufacturer of diabetic care devices, has more than doubled its interim sales to £1.1 million ($1.7 million) in the six months to September compared with £431,000 in the previous year. The after-tax loss fell to £97,000 from £515,000. CEO Keith Drew says the results are "still unsatisfactory, [but] encouraging". Drew's US distributor, Bio-Rad, launched DiaSTAT in the US and is extending into markets outside the US.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT094508

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel